tendino-musculaire sérocytol zäpfchen
sérolab, société anonyme - globulina equina (immun mit stoff ostéocartilagineux und bindegewebe, muskeln, sehnen, sérueuses schweine) - zäpfchen - globulina equina (immun mit stoff ostéocartilagineux und bindegewebe, muskeln, sehnen, sérueuses schweine) 8 mg, propylenglycolum, conserv.: propylis parahydroxybenzoas, e 218, excipiens pro suppositorio. - behandlung immunomodulant laut dr. thomas; beschäftigungsmöglichkeiten siehe fachinformation - andere komplementärarzneimittel
sandoglobulina
emra-med arzneimittel gmbh (3263935) - normales immunglobulin vom menschen zur intramuskulären anwendung - trockensubstanz und lösungsmittel - normales immunglobulin vom menschen zur intramuskulären anwendung (17596) 96 prozentgehalt masse in masse
stickstoff medizinisch air liquide
air liquide austria gmbh - stickstoff - medical gases
phenhydan injektionslösung
desitin arzneimittel gmbh (3000816) - phenytoin-natrium - injektionslösung - phenytoin-natrium (00539) 271,75 milligramm
phenhydan
desitin arzneimittel gmbh (3000816) - phenytoin - tablette - phenytoin (00114) 100 milligramm
imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
phenhydan tabletten
desitin pharma gmbh - phenytoinum - tabletten - phenytoinum 100 mg, cellulosum microcristallinum, maydis amylum, carboxymethylamylum natricum a corresp. natrium 0.38 mg, silicii dioxidum praecipitatum, gelatina, silica colloidalis anhydrica, magnesii stearas, talcum, aqua purificata, pro compresso. - antiepilepticum - synthetika
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastische mittel - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
beriglobin p fertigspritze injektionslösung zur subkutanen oder intramuskulären anwendung
csl behring gmbh - immunglobulin - normal human immunoglobul
intratect 10% infusionslösung
biotest (schweiz) ag - immunoglobulinum humanum normale - infusionslösung - proteina plasmatis humani 100 mg aus, immunoglobulinum menschliche normale min. 96 %, glycinum, wasser q.s. zu einer lösung anstelle von 1 ml. - immunmodulation bei idiopathischer thrombozytopenischer purpura (itp) ; immunmodulation bei kawasaki-syndrom; allogene knochenmarktransplantation; substitutionstherapie bei primären immunmangelkrankheiten; substitutionstherapie bei myelom oder chronisch-lympathischer leukämie mit schwerer sekundärer hypogammaglobulinänämie und rezidivierenden infektionen; immunmodulation bei gullain-barré syndrom (gbs); substitutionstherapie bei kindern mit kongenitalem aids und rezidivierenden infektionen - blutprodukte